Needham & Company LLC Cuts Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $55.00
Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its price target trimmed by Needham & Company LLC from $60.00 to $55.00 in a research report report published on Tuesday,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on XENE. The Goldman Sachs […]
Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its price target trimmed by Needham & Company LLC from $60.00 to $55.00 in a research report report published on Tuesday,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on XENE. The Goldman Sachs […]
